• Ads by Google:

  • About Me

    In 1994 I was diagnosed with celiac disease, which led me to create Celiac.com in 1995. I created this site for a single purpose: To help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives. Celiac.com was the first site on the Internet dedicated solely to celiac disease. In 1998 I founded The Gluten-Free Mall, Your Special Diet Superstore!, and I am the co-author of the book Cereal Killers, and founder and publisher of Journal of Gluten Sensitivity.

  • Popular Contributors

  • Ads by Google:

  • Who's Online   14 Members, 0 Anonymous, 712 Guests (See full list)

  • Related Articles

    Scott Adams
    Associazione Famiglie Bambini Celiachi
    Contact: Emilia Romague
    Via Masia 21
    I-40138 Bologna, Italy
    Tel: 39/51/391980
    A.I.C. Associazione Italiana Celiachia
    Home page: http://www.celiachia.it/
    Contact: Anna Maria Vallesi
    Via Picotti 22
    56124 Pisa, Italy
    Tel/Fax: +39 (50) 580939
    E-Mail: aic@cibernet.it
    Ancona
    Group: Marche
    Contact: Ratini Paolo
    Via A.Rocca, 20
    60011 Arcevia (Ancona)
    Tel. +39-731-9047
    Bologna
    Group: Assoc Famigilie Bambini Celiaci
    Contact: Silvio Costantini
    Via Masia 21
    I-40138 Bolgna
    Tel. +39-51-391980
    Bolzano
    Group: Alto Adige
    Contact: Sinn Franz
    Via Am Eichamt, 29
    39050 Cornaiano (Bolzano)
    Tel. +39-471-662424
    Cagliari
    Group: Sardegna
    Contact: Maria Teresa Russo
    Via Sassari, 69
    09121 Cagliari
    Tel. +39-70-652912

    Capoterra
    Resource of Italy
    Contact: Luigi Delussu
    Strada 47, Poggio dei Pini
    09012 Capoterra CA
    Tel: 39 70 725483
    E-mail: luigi.delussu@galactica.it,
    or gioppo@freenet.hut.fi
    Catanzaro
    Contact: Quattromani Antonio
    Via Brigata, 7
    88100 Catanzaro
    Tel. +39-961-782310
    Foggia
    Group: Puglia - Basilicata
    Contact: Gasperi Anna Maria Pia
    Via Padre Ardelio della Bella, 13
    71100 Foggia
    Tel. +39-881-686930
    Genova
    Group: Liguria
    Contact: Spanio Barbara
    Via Telesio, 4/3
    16145 Genova
    Tel. +39-10-319232
    Italian Coeliac Association
    Piazza Costituzione Italiana, 2
    50023 Figline Valdarno
    Firenze
    Milano
    Group: Lombardia
    Piazza Erculea, 11
    20122 Milano
    Tel./Fax: +39-2-86.78.20
    Napoli
    Group: Campania
    Via Fiorentine a Chiaia, 9
    80122 Napoli
    Tel. +39-81-7612112
    Palermo
    Group: Sicilia
    Donizetti, 12
    90134 Palermo
    Tel./Fax. +39-91-320702
    Perugia
    Group: Umbria
    Contact: Pellicori Spinelli Elsa
    Via Cortonese, 74/A
    06127 Perugia
    Tel. +39-75-5007369
    Pescara
    Group: Abruzzo
    Contact: Innamorati Paolo
    Via Botticelli, 53
    65100 Pescara
    Tel. +39-85-4210355
    Prato
    Group: Toscanav
    Contact: Ricci Viviana
    Viale Montegrappa, 314
    50047 Prato
    Tel. +39-574-583169
    Reggio Emilia
    Group: Emilia Romagna
    Contact: Gualtieri Mauro
    Via Bonazza, 22
    42016 S.Giorgio Di Guastalla (Reggio Emilia)
    Tel. +39-522-830328
    Roma
    Group: Lazio
    Contact: Sgroi Maria Rosa
    Via dei Giovi, 45
    00141 Roma
    Tel. +39-6-87181786
    Torino
    Group: Piemonte - Valle dAosta
    Contact: Lucia Bramante
    Via Palestro, 11bis
    10036 Settimo Torinese (Torino)
    Tel. +39-11-8950476
    Trento
    Contact: Vettori Elsa
    Loc.Man S.Antonio, 25
    38050 Villazzano (Trento)
    Tel. +39-461-922117
    Treviso
    Group: Veneto
    Contact: Finardi Umberto
    Via Fabia, 17/9
    31010 One Di Fonte (Treviso)
    Tel. +39-423-948166
    Trieste
    Group: Friuli Venezia Giulia
    Contact: Spinelli Caterina
    Via Tolmezzo, 8
    34100 Trieste
    Tel. +39-40-422472

    Scott Adams
    Oslo
    Norsk Coliakiforening
    Prinsens Gate 6.5. etg.
    N-0152 Oslo, Norway
    Tel: 47/22/42/60/01 (Tues. & Wed)
    Fax: 47/22/42/60/04
    Norweigean Coeliac Association.
    Karsten Kronholm
    Medisinsk rådgjevar (medical adviser)
    Sogn og Fjordane fylkeskommune (county)
    Telf. 57 65 38 58.
    Privat-adr. Henjahaugane 17, 5842 Leikanger
    The Norwegian Coeliac Society
    Sandakerveien 99
    PB 4725 Nydalen
    0421 OSLO
    NORWAY
    Telf. (+47) 22 79 91 70 Fax 22 79 93 95

    E-mail: norcoe@online.no
    International contact :
    (Also : Director of the Board of Association of European Coeliac Societies)
    Karsten Kronholm M.D. telf private : (+47) 57 65 38 58 Mobil : (+47) 415 30 390
    E-mail: k-kronho@online.no
    Henjahaugane 17
    6863 Leikanger.

  • Recent Articles

    Jefferson Adams
    Celiac.com 06/21/2018 - Would you buy a house advertised as ‘gluten-free’? Yes, there really is such a house for sale. 
    It seems a Phoenix realtor Mike D’Elena is hoping that his trendy claim will catch the eye of a buyer hungry to avoid gluten, or, at least one with a sense of humor. D’Elena said he crafted the ads as a way to “be funny and to draw attention.” The idea, D’Elena said, is to “make it memorable.” 
    Though D’Elena’s marketing seeks to capitalizes on the gluten-free trend, he knows Celiac disease is a serious health issue for some people. “[W]e’re not here to offend anybody….this is just something we're just trying to do to draw attention and do what's best for our clients," he said. 
    Still, the signs seem to be working. D'elena had fielded six offers within a few days of listing the west Phoenix home.
    "Buying can sometimes be the most stressful thing you do in your entire life so why not have some fun with it," he said. 
    What do you think? Clever? Funny?
    Read more at Arizonafamily.com.

    Advertising Banner-Ads
    Bakery On Main started in the small bakery of a natural foods market on Main Street in Glastonbury, Connecticut. Founder Michael Smulders listened when his customers with Celiac Disease would mention the lack of good tasting, gluten-free options available to them. Upon learning this, he believed that nobody should have to suffer due to any kind of food allergy or dietary need. From then on, his mission became creating delicious and fearlessly unique gluten-free products that were clean and great tasting, while still being safe for his Celiac customers!
    Premium ingredients, bakeshop delicious recipes, and happy customers were our inspiration from the beginning— and are still the cornerstones of Bakery On Main today. We are a fiercely ethical company that believes in integrity and feels that happiness and wholesome, great tasting food should be harmonious. We strive for that in everything we bake in our dedicated gluten-free facility that is GFCO Certified and SQF Level 3 Certified. We use only natural, NON-GMO Project Verified ingredients and all of our products are certified Kosher Parve, dairy and casein free, and we have recently introduced certified Organic items as well! 
    Our passion is to bake the very best products while bringing happiness to our customers, each other, and all those we meet!
    We are available during normal business hours at: 1-888-533-8118 EST.
    To learn more about us at: visit our site.

    Jefferson Adams
    Celiac.com 06/20/2018 - Currently, the only way to manage celiac disease is to eliminate gluten from the diet. That could be set to change as clinical trials begin in Australia for a new vaccine that aims to switch off the immune response to gluten. 
    The trials are set to begin at Australia’s University of the Sunshine Coast Clinical Trials Centre. The vaccine is designed to allow people with celiac disease to consume gluten with no adverse effects. A successful vaccine could be the beginning of the end for the gluten-free diet as the only currently viable treatment for celiac disease. That could be a massive breakthrough for people with celiac disease.
    USC’s Clinical Trials Centre Director Lucas Litewka said trial participants would receive an injection of the vaccine twice a week for seven weeks. The trials will be conducted alongside gastroenterologist Dr. James Daveson, who called the vaccine “a very exciting potential new therapy that has been undergoing clinical trials for several years now.”
    Dr. Daveson said the investigational vaccine might potentially restore gluten tolerance to people with celiac disease.The trial is open to adults between the ages of 18 and 70 who have clinically diagnosed celiac disease, and have followed a strict gluten-free diet for at least 12 months. Anyone interested in participating can go to www.joinourtrials.com.
    Read more at the website for Australia’s University of the Sunshine Coast Clinical Trials Centre.

    Source:
    FoodProcessing.com.au

    Jefferson Adams
    Celiac.com 06/19/2018 - Could baking soda help reduce the inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease? Scientists at the Medical College of Georgia at Augusta University say that a daily dose of baking soda may in fact help reduce inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease.
    Those scientists recently gathered some of the first evidence to show that cheap, over-the-counter antacids can prompt the spleen to promote an anti-inflammatory environment that could be helpful in combating inflammatory disease.
    A type of cell called mesothelial cells line our body cavities, like the digestive tract. They have little fingers, called microvilli, that sense the environment, and warn the organs they cover that there is an invader and an immune response is needed.
    The team’s data shows that when rats or healthy people drink a solution of baking soda, the stomach makes more acid, which causes mesothelial cells on the outside of the spleen to tell the spleen to go easy on the immune response.  "It's most likely a hamburger not a bacterial infection," is basically the message, says Dr. Paul O'Connor, renal physiologist in the MCG Department of Physiology at Augusta University and the study's corresponding author.
    That message, which is transmitted with help from a chemical messenger called acetylcholine, seems to encourage the gut to shift against inflammation, say the scientists.
    In patients who drank water with baking soda for two weeks, immune cells called macrophages, shifted from primarily those that promote inflammation, called M1, to those that reduce it, called M2. "The shift from inflammatory to an anti-inflammatory profile is happening everywhere," O'Connor says. "We saw it in the kidneys, we saw it in the spleen, now we see it in the peripheral blood."
    O'Connor hopes drinking baking soda can one day produce similar results for people with autoimmune disease. "You are not really turning anything off or on, you are just pushing it toward one side by giving an anti-inflammatory stimulus," he says, in this case, away from harmful inflammation. "It's potentially a really safe way to treat inflammatory disease."
    The research was funded by the National Institutes of Health.
    Read more at: Sciencedaily.com

    Jefferson Adams
    Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown.  To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. 
    The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
    For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. 
    The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis.
    Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed.
    Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults.
    This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. 
    This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries.  The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A.
    Source:
    Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.